VI-RADS Scoring Criteria for Alternative Risk-adapted Strategies in the Management of Bladder Cancer During the COVID-19 Pandemic

Uro-Oncology

Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection

Eur Urol.

Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V

doi: 10.1016/j.eururo.2019.09.029.

Uro-Oncology

Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic

Eur Urol.

Wallis CJD, Novara G, Marandino L, Bex A, Kamat AM, Karnes RJ, Morgan TM, Mottet N, Gillessen S, Bossi A, Roupret M, Powles T, Necchi A, Catto JWF, Klaassen Z

doi: 10.1016/j.eururo.2020.04.063.

Uro-Oncology

Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic

Eur Urol.

Louis L, Thomas S, Yohann L, Morgan R

doi: 10.1016/j.eururo.2020.04.039.

Uro-Oncology

Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus Statement

BJU Int.

Tandogdu Z, Collins J, Shaw G, Rohn J, Koves B, Sachdeva A, Ghazi A, Haese A, Mottrie A, Kumar A, Sivaraman A, Tewari A, Challacombe B, Rocco B, Giedelman C, Wagner C, Rogers CG, Murphy DG, Pushkar D, Ogaya-Pinies G, Porter J, Ramesh Seetharam K, Graefen M, Orvieto MA, Covas Moschovas M, Schatloff O, Wiklund P, Coelho R, Valero R, de Reijke TM, Ahlering T, Rogers T, van der Poel HG, Patel V, Artibani W, Wagenlehner F, Nathan S, Erik Bjerklund Johansens T, Hawkey P, Kelly J

doi: 10.1111/bju.15299.

Uro-Oncology

Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres

Eur Urol.

Campi R, Amparore D, Capitanio U, Checcucci E, Salonia A, Fiori C, Minervini A, Briganti A, Carini M, Montorsi F, Serni S, Porpiglia F

doi: 10.1016/j.eururo.2020.03.054.

Uro-Oncology

Risk Adapted Management of Low-Grade Bladder Tumors: Recommendations from the International Bladder Cancer Group

BJU Int.

Matulay JT, Soloway M, Witjes JA, Buckley R, Persad R, Lamm DL, Boehle A, Palou J, Colombel M, Brausi M, Kamat AM

doi: 10.1111/bju.14995.

Reproductive Health

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

BMC Med.

Kyrou I, Karteris E, Robbins T, Chatha K, Drenos F, Randeva HS

doi: 10.1186/s12916-020-01697-5.

HPV and Gynecologic Cancer

Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer

Am J Obstet Gynecol.

Frey MK, Ellis AE, Zeligs K, Chapman-Davis E, Thomas C, Christos PJ, Kolev V, Prasad-Hayes M, Cohen S, Holcomb K, Blank SV

doi: 10.1016/j.ajog.2020.06.049.

Uro-Oncology

The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort

BJU Int.

Muilwijk T, Akand M, Soria F, Giordano A, Milenkovic U, Moris L, Gevaert T, Van Poppel H, Albersen M, Gontero P, Joniau S

doi: 10.1111/bju.15163.

Related content

Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection

Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic

Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guérin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic

Management of patients who opt for radical prostatectomy during the COVID-19 pandemic: An International Accelerated Consensus Statement

Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres

Risk Adapted Management of Low-Grade Bladder Tumors: Recommendations from the International Bladder Cancer Group

Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic

Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer

The Cancer of the Bladder Risk Assessment (COBRA) score for Estimating Cancer-Specific Survival after Radical Cystectomy: External Validation in a Large Bi-institutional Cohort